The Authors’ Own Words: Co-prescription of Naloxone as a Universal Precautions Model for Patients on Chronic Opioid Therapy

The Authors’ Own Words: We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Co-prescription of Naloxone as a Universal Precautions Model for Patients on Chronic Opioid Therapy – observational study

Mikiko Y. Takeda, PharmD, MS; Joanna G. Katzman, MD, MSPH; Ernest Dole, PharmD; Melissa Heinz Bennett, MPH; Amal Alchbli, MD; Daniel Duhigg, DO, MBA; & Howard Yonas, MD

Substance Abuse Vol. 37, Iss. 4, 2016

“Since opioid overdose death is such a pressing public health issue, harm reduction innovations to prevent overdose death are critical to study. The ambulatory co-prescribing of naloxone is a universal precaution model for all patients prescribed chronic opioid therapy. This can be adapted universally for all patients treated with chronic opioid therapy in an ambulatory setting so that there is increased availability and utilization in the case of an opioid overdose.”